Company: INMB
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001213900-25-041072
Chunk: 57

Company: Inmune Bio, Inc.
Filing Date: 2025-05-08
Form: 10-Q
Item: Part I, Item 2
Chunk 57
---
5  
    2024  
    Change 
  
    Revenues 
    $50  
    $14  
    $36 
  
    Operating expenses: 

    Research and development 
     7,639  
     8,693  
     (1,054)
  
    General and administrative 
     2,316  
     2,338  
     (22)
  
    Total operating expenses 
     9,955  
     11,031  
     (1,076)
  
    Loss from operations 
     (9,905) 
     (11,017) 
     1,112 
  
    Other expense, net 
     166  
     (8) 
     174 
  
    Net loss 
    $(9,739) 
    $(11,025) 
    $1,286 

Revenues

During the three months ended
March 31, 2025 and 2024, the Company sold MSC’s to third-parties and recognized $50,000 and $14,000, respectively, of revenues.

General and Administrative

General and administrative
expenses were approximately $2.3 million during each of the three months ended March 31, 2025 and 2024, respectively.

Research and Development

Research and development expenses
were approximately $7.6 million during the three months ended March 31, 2025, compared to approximately $8.7 million during the three
months ended March 31, 2024. The change in research and development expenses during the three months ending March 31, 2025 compared to
the three months ending March 31, 2024 is largely due to incurring $1.5 million less expenses related to our Alzheimer’s clinical
program due to the Company nearing the completion of the Phase 2 clinical trial, partially offset by $0.3 million of higher employee compensation
costs and a decrease of $0.2 million of accrued rebate.

Other Expense, net

During the three months ended
March 31, 2025, the Company recorded $0.2 million of other income due to the Company earning interest income on its cash investments.
The increase in other income from the prior year is due to the Company paying off its debt in 2024.

24

Liquidity and Capital Resources

Liquidity
is the ability of a company to generate funds to